July 20, 2026
ALZAI Health Corp.
ISIN: CA02262P1036
ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology
TORONTO, ONTARIO – July 20, 2026 – ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into an exclusive worldwide license agreement...
Read more >>ALZAI Health Corp. Signs Strategic U.S. Commercialization Agreement With Centauri Health Solutions to Advance AI-Driven Alzheimer’s Risk Identification
TORONTO, ONTARIO – July 2, 2026 - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into a strategic teaming agreement (the "Agreement") with Centauri Health Solutions ("Centauri"), a leading U.S. healthcare technology company serving 60 million members through advanced mission-critical technology,...
Read more >